Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Cancer|February 20, 2018
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancerMichaela Poliaková, Daniel M Aebersold, Yitzhak Zimmer, et al.
The FEBS Journal|April 18, 2019
Metabolomics reveals tepotinib-related mitochondrial dysfunction in MET-activating mutations-driven modelsMichaela Poliaková, Andrea Felser, Katarzyna Pierzchala, et al.
Molecular Cancer|May 24, 2017
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer modelsLluís Nisa, Pascal Häfliger, Michaela Poliaková, et al.
Oncogene|May 3, 2018
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxiaAstrid A Glück, Eleonora Orlando, Dominic Leiser, et al.
Cancer Research Communications|July 3, 2024
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response NetworkMichaela Poliaková Turan, Rahel Riedo, Matúš Medo, et al.
Molecular Cancer Research : MCR|August 16, 2018
Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent DiseaseLluís Nisa, David Barras, Michaela Medová, et al.
Pageof 1